SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-125195
Filing Date
2022-12-07
Accepted
2022-12-07 16:31:20
Documents
2
Group Members
HIGHCAPE CAPITAL, LLCHIGHCAPE CO-INVESTMENT VEHICLE I, LLCHIGHCAPE CO-INVESTMENT VEHICLE II, LLCHIGHCAPE PARTNERS GP II, L.P.HIGHCAPE PARTNERS GP II, LLCHIGHCAPE PARTNERS GP, L.P.HIGHCAPE PARTNERS GP, LLCHIGHCAPE PARTNERS II, L.P.HIGHCAPE PARTNERS QP II,

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2232148d2_sc13d.htm SC 13D/A 220967
2 EXHIBIT 1 tm2232148d2_ex1.htm EX-1 28683
  Complete submission text file 0001104659-22-125195.txt   251754
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Subject) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92213 | Film No.: 221450515
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10751 FALLS ROAD SUITE 300 BALTIMORE MD 21093
Business Address 10751 FALLS ROAD SUITE 300 BALTIMORE MD 21093 (410) 375-0050
HighCape Capital, L.P. (Filed by) CIK: 0001826279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A